Raymond James & Associates Pluristem Therapeutics Inc Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022
SELL
$1.46 - $3.1 $14,972 - $31,790
-10,255 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$4.48 - $8.49 $26,920 - $51,016
-6,009 Reduced 36.95%
10,255 $49,000
Q4 2020

Feb 12, 2021
SELL
$5.93 - $11.46 $119,803 - $231,526
-20,203 Reduced 55.4%
16,264 $115,000
Q3 2020

Nov 04, 2020
BUY
$8.4 - $11.48 $161,691 - $220,978
19,249 Added 111.8%
36,467 $384,000
Q2 2020

Jul 28, 2020
BUY
$3.25 - $12.43 $20,475 - $78,309
6,300 Added 57.7%
17,218 $152,000
Q4 2019

Feb 12, 2020
SELL
$3.19 - $4.21 $4,306 - $5,683
-1,350 Reduced 11.0%
10,918 $43,000
Q3 2019

Nov 07, 2019
BUY
$3.46 - $6.1 $42,447 - $74,834
12,268 New
12,268 $46,000

About PLURISTEM THERAPEUTICS INC

PSTI Quotes by TradingView
  • Ticker PSTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,347,600
  • Market Cap $32.3M
More about PSTI
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email